IGAM
TEVA icon

iA Global Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

iA Global Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
341,622
+42,587
+14% +$1.42M 0.14% 122
2026
Q1 		$9.01M Buy
299,035
+91,026
+44% +$2.93M 0.13% 145
2025
Q4 		$6.49M Sell
208,009
-700
-0.3% -$17.2K 0.08% 172
2025
Q3 		$4.22M Buy
208,709
+18,100
+9% +$318K 0.06% 193
2025
Q2 		$3.19M Sell
190,609
-3,731
-2% -$60.2K 0.05% 203
2025
Q1 		$2.99M Sell
194,340
-160,779
-45% -$2.87M 0.05% 201
2024
Q4 		$7.83M Sell
355,119
-85,772
-19% -$1.56M 0.14% 118
2024
Q3 		$7.95M Buy
440,891
+21,816
+5% +$382K 0.14% 110
2024
Q2 		$6.81M Buy
419,075
+313,535
+297% +$4.83M 0.13% 120
2024
Q1 		$1.49M Buy
+105,540
New +$1.33M 0.03% 266

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

iA Global Asset Management's TEVA Position: Q2 2026 in Review

iA Global Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 14% in Q2 2026, buying an estimated $1.42M and bringing the position to 341,622 shares worth $11.6M. The position accounts for 0.14% of the portfolio, ranked #122.

iA Global Asset Management first reported a position in TEVA in Q1 2024 and has held it in 10 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • iA Global Asset Management held 341,622 shares of Teva Pharmaceuticals worth $11.6M as of Q2 2026.
  • iA Global Asset Management bought 42,587 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.42M.
  • Teva Pharmaceuticals made up 0.14% of iA Global Asset Management's portfolio in Q2 2026, its #122 holding.
  • iA Global Asset Management first reported a position in Teva Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on iA Global Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.